Stock Events

Icon 

$220.4
-$1.71-0.77% Friday 20:00

Statistiche

In rialzo oggi
226.78
In ribasso oggi
219.81
In rialzo da 52 settimane
347.72
In ribasso da 52 settimane
219.81
Volume
1,493,210
Volume medio
805,937
Cap. di mercato
26.67B
Rapporto P/E
37.45
Rendimento da dividendi
-
Dividendo
-

Prossimamente

Guadagni

23OctAtteso
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
0
1.28
2.57
3.85
EPS attesi
3.850697
EPS effettivi
3.35

Le persone seguono anche

Questo elenco si basa sulle watchlist delle persone su Stock Events che seguono ICLR. Non rappresenta una raccomandazione d'investimento.

Concorrenti

Questo elenco è un'analisi basata su recenti eventi di mercato. Non è una raccomandazione di investimento.

Rating degli analisti

288.33$Obiettivo di prezzo medio
La stima più elevata è $350.
Da 9 valutazioni negli ultimi 6 mesi. Non rappresenta una raccomandazione d'investimento.
Acquista
78%
Detenuti
22%
Vendi
0%

Info

Health Technology
Pharmaceuticals: Other
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Show more...
CEO
Stephen Cutler
Dipendenti
41100
Paese
IE
ISIN
IE0005711209

Quotazioni